All In Biotech

Drug Trial Radar · NCT02568267

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients With Locally Advanced or Metastatic Solid Tumors That Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

534

Actual

Start

Nov 19, 2015

Primary completion

Oct 29, 2026

Study completion Oct 29, 2026

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Oct 5, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor an NTRK1/2/3, ROS1, or ALK gene fusion. Patients will be assigned to different baskets according to tumor type and gene fusion.

Conditions

  • Breast Cancer
  • Cholangiocarcinoma
  • Colorectal Cancer
  • Head and Neck Neoplasms
  • Lymphoma, Large-Cell, Anaplastic
  • Melanoma
  • Neuroendocrine Tumors
  • Non-Small Cell Lung Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Papillary Thyroid Cancer
  • Primary Brain Tumors
  • Renal Cell Carcinoma
  • Sarcomas
  • Salivary Gland Cancers
  • Adult Solid Tumor

Interventions

  • EntrectinibDrug

    TrkA/B/C, ROS1, and ALK inhibitor

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective Response RateTime frame: Approximately 24 months

Locations

115 sites in 16 countries. Site status is shown where the registry gives one.

  • Dignity Health St Joseph's Hospital and Medical Center

    Phoenix, Arizona

  • Mayo Clinic

    Phoenix, Arizona

  • City of Hope Cancer Center

    Duarte, California

  • City of Hope Duarte - Comprehensive Cancer Center, Investigational Drug Services

    Duarte, California

  • Scripps Clinic

    La Jolla, California

  • University of California San Diego Moores Cancer Center

    La Jolla, California

  • Southern California Kaiser Permanente

    Los Angeles, California

  • Univ Of California Irvine College Of Medicine

    Orange, California

  • UCSF Mount Zion Medical Ctr

    San Francisco, California

  • UCSF Mission Bay

    San Francisco, California

  • Sarcoma Oncology Center

    Santa Monica, California

  • Sarcoma Oncology Research Center LLC

    Santa Monica, California

  • University of Colorado Cancer Center

    Aurora, Colorado

  • Yale University

    New Haven, Connecticut

  • Georgetown University Medical Center Lombardi Cancer Center

    Washington D.C., District of Columbia

  • Florida Cancer Specialists - Sarasota

    Sarasota, Florida

  • H. Lee Moffitt Cancer Center and Research Inst.

    Tampa, Florida

  • Moffitt Cancer Center

    Tampa, Florida

  • University Cancer & Blood Center, LLC

    Athens, Georgia

  • Winship Cancer Institute

    Atlanta, Georgia

  • Southeastern Regional Medical Center, Inc.

    Newnan, Georgia

  • Northwestern University

    Chicago, Illinois

  • Advocate Medical Group - Park Ridge, Luther Lane - Oncology

    Park Ridge, Illinois

  • Midwestern Regional Medical Center

    Zion, Illinois

  • Weinberg Cancer Institution at Franklin Square

    Baltimore, Maryland

  • Massachusetts General Hosp CAR

    Boston, Massachusetts

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts

  • Dana Farber Cancer Institute

    Boston, Massachusetts

  • Karmanos Cancer Center

    Detroit, Michigan

  • Henry Ford Hospital

    Detroit, Michigan

  • Regents of the University of Minnesota

    Minneapolis, Minnesota

  • Washington University

    St Louis, Missouri

  • Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley

    Las Vegas, Nevada

  • North Shore Hem Onc Associates

    East Setauket, New York

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Atrium Health Levine Cancer Institute

    Charlotte, North Carolina

  • Levine Cancer Institute

    Charlotte, North Carolina

  • Duke Cancer Institute

    Durham, North Carolina

  • Ohio State University

    Columbus, Ohio

Showing 40 of 115 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.